Comparison Of Long-Term Survival And Cost-Effectiveness (Ce) Of First-Line (1l) Treatment Options In Advanced Renal Cell Carcinoma (Arcc) With Intermediate Or Poor (I/P) Prognostic Risk
Annals of Oncology（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要